SCHEMBL21067741

SCHEMBL21067741

O=[N+]([O-])c1ccc2c(ccn2[C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)c1

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TYMS P04818 5/20 0.58
▸ DUT P33316 1/20 0.46
▸ POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21067742 1.00 TYMS (0.58) TYMSDUTPOLB
SCHEMBL10183365 0.86 SLC29A1 (0.47) TYMS
SCHEMBL13030145 0.86 SLC29A1 (0.47) TYMS
SCHEMBL12732344 0.86 SLC29A1 (0.47) TYMS
SCHEMBL2946371 0.86 SLC29A1 (0.47) TYMS
SCHEMBL15146568 0.79 TYMS (0.37) TYMS
SCHEMBL12254971 0.79 TYMS (0.37) TYMS
SCHEMBL26757647 0.78 TYMS (0.37) TYMS
SCHEMBL26757255 0.78 TYMS (0.37) TYMS
Deoxyuridine Monophosphate SCHEMBL25024676 0.73 DUT (0.77) TYMSDUT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 — — US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 — — US disclosed
Send feedback